BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 19838863)

  • 1. Impulsive choice and response in dopamine agonist-related impulse control behaviors.
    Voon V; Reynolds B; Brezing C; Gallea C; Skaljic M; Ekanayake V; Fernandez H; Potenza MN; Dolan RJ; Hallett M
    Psychopharmacology (Berl); 2010 Jan; 207(4):645-59. PubMed ID: 19838863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease.
    Leroi I; Barraclough M; McKie S; Hinvest N; Evans J; Elliott R; McDonald K
    J Neuropsychol; 2013 Sep; 7(2):306-25. PubMed ID: 23901888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical spectrum of impulse control disorders in Parkinson's disease.
    Weintraub D; David AS; Evans AH; Grant JE; Stacy M
    Mov Disord; 2015 Feb; 30(2):121-7. PubMed ID: 25370355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.
    Girard R; Obeso I; Thobois S; Park SA; Vidal T; Favre E; Ulla M; Broussolle E; Krack P; Durif F; Dreher JC
    Brain; 2019 Jan; 142(1):146-162. PubMed ID: 30590514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptual decision-making in patients with Parkinson's disease.
    Djamshidian A; O'Sullivan SS; Lawrence AD; Foltynie T; Aviles-Olmos I; Magdalinou N; Tomassini A; Warner TT; Lees AJ; Averbeck BB
    J Psychopharmacol; 2014 Dec; 28(12):1149-54. PubMed ID: 25237123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impulse control disorders in Parkinson's disease: Review of pathophysiology, epidemiology, clinical features, management, and future challenges.
    Bhattacharjee S
    Neurol India; 2018; 66(4):967-975. PubMed ID: 30038082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulse control disorders in Parkinson disease: A cross-sectional study in Morocco.
    El Otmani H; Mouni FZ; Abdulhakeem Z; Attar Z; Rashad L; Saali I; El Moutawakil B; Rafai MA; Slassi I; Nadifi S
    Rev Neurol (Paris); 2019 Apr; 175(4):233-237. PubMed ID: 30935674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impulsive and compulsive behaviors during dopamine replacement treatment in Parkinson's Disease and other disorders.
    Raja M; Bentivoglio AR
    Curr Drug Saf; 2012 Feb; 7(1):63-75. PubMed ID: 22663960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine and impulse control disorders in Parkinson's disease.
    Weintraub D
    Ann Neurol; 2008 Dec; 64 Suppl 2(Suppl 2):S93-100. PubMed ID: 19127573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study.
    Marques A; Figorilli M; Pereira B; Derost P; Debilly B; Beudin P; Vidal T; Durif F; Fantini ML
    Sleep Med; 2018 Aug; 48():148-154. PubMed ID: 29913341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impulse Control Disorders in the Polish Population of Patients with Parkinson's Disease.
    Toś M; Grażyńska A; Antoniuk S; Siuda J
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629758
    [No Abstract]   [Full Text] [Related]  

  • 13. [Impulsive-compulsive behaviours in a German Parkinson's disease outpatient sample].
    Rohde K; Riedel O; Lueken U; Rietzel S; Fauser M; Ossig C; Reichmann H; Storch A
    Fortschr Neurol Psychiatr; 2013 Sep; 81(9):503-10. PubMed ID: 23986458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impulse control disorders in Parkinson's disease.
    Weintraub D; Potenza MN
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine agonists and risk: impulse control disorders in Parkinson's disease.
    Voon V; Gao J; Brezing C; Symmonds M; Ekanayake V; Fernandez H; Dolan RJ; Hallett M
    Brain; 2011 May; 134(Pt 5):1438-46. PubMed ID: 21596771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.
    Lopez AM; Weintraub D; Claassen DO
    Semin Neurol; 2017 Apr; 37(2):186-192. PubMed ID: 28511259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of impulse control disorders in Parkinson's disease: Practical considerations and future directions.
    Ramirez-Zamora A; Gee L; Boyd J; Biller J
    Expert Rev Neurother; 2016; 16(4):389-99. PubMed ID: 26923084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
    Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
    Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictors and modifiers of impulse control disorders in Parkinson`s disease].
    Sapronova MR; Shnayder NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):145-156. PubMed ID: 28635753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort.
    Jesús S; Labrador-Espinosa MA; Adarmes AD; Méndel-Del Barrio C; Martínez-Castrillo JC; Alonso-Cánovas A; Sánchez Alonso P; Novo-Ponte S; Alonso-Losada MG; López Ariztegui N; Segundo Rodríguez JC; Morales MI; Gastón I; Lacruz Bescos F; Clavero Ibarra P; Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; Martínez-Martín P; Santos-García D; Mir P;
    Sci Rep; 2020 Oct; 10(1):16893. PubMed ID: 33037247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.